Synthesis of novel analogs of cabergoline: improving cardiovascular safety by removing 5-HT2B receptor agonism.
about
Role of "old" pharmacological agents in the treatment of Cushing's syndromeErgot Alkaloids (Re)generate New Leads as Antiparasitics.Total synthesis of dihydrolysergic acid and dihydrolysergol: development of a divergent synthetic strategy applicable to rapid assembly of D-ring analogs.Crystal structure of rac-3-[2,3-bis-(phenyl-sulfan-yl)-3H-indol-3-yl]propanoic acid
P2860
Synthesis of novel analogs of cabergoline: improving cardiovascular safety by removing 5-HT2B receptor agonism.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Synthesis of novel analogs of ...... oving 5-HT2B receptor agonism.
@ast
Synthesis of novel analogs of ...... oving 5-HT2B receptor agonism.
@en
type
label
Synthesis of novel analogs of ...... oving 5-HT2B receptor agonism.
@ast
Synthesis of novel analogs of ...... oving 5-HT2B receptor agonism.
@en
prefLabel
Synthesis of novel analogs of ...... oving 5-HT2B receptor agonism.
@ast
Synthesis of novel analogs of ...... oving 5-HT2B receptor agonism.
@en
P2093
P2860
P356
P1476
Synthesis of novel analogs of ...... oving 5-HT2B receptor agonism.
@en
P2093
Michael A Walters
Peter I Dosa
Suck Won Kim
P2860
P304
P356
10.1021/ML3003814
P577
2013-02-01T00:00:00Z